Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent
- 2 December 2004
- journal article
- Published by Elsevier
- Vol. 174 (3) , 1070-1076
- https://doi.org/10.1016/0006-291x(91)91529-l
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4JNCI Journal of the National Cancer Institute, 1990
- Isolation of fatty acid amide as an angiogenic principle from bovine mesenteryBiochemical and Biophysical Research Communications, 1990
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin FragmentScience, 1985
- Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor.The Journal of cell biology, 1985
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983
- Protamine is an inhibitor of angiogenesisNature, 1982
- TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATEThe Lancet, 1964